235 related articles for article (PubMed ID: 20703247)
1. Functional redundancy of Langerhans cells and Langerin+ dermal dendritic cells in contact hypersensitivity.
Noordegraaf M; Flacher V; Stoitzner P; Clausen BE
J Invest Dermatol; 2010 Dec; 130(12):2752-9. PubMed ID: 20703247
[TBL] [Abstract][Full Text] [Related]
2. Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity.
Bennett CL; van Rijn E; Jung S; Inaba K; Steinman RM; Kapsenberg ML; Clausen BE
J Cell Biol; 2005 May; 169(4):569-76. PubMed ID: 15897263
[TBL] [Abstract][Full Text] [Related]
3. Acute ablation of Langerhans cells enhances skin immune responses.
Bobr A; Olvera-Gomez I; Igyarto BZ; Haley KM; Hogquist KA; Kaplan DH
J Immunol; 2010 Oct; 185(8):4724-8. PubMed ID: 20855870
[TBL] [Abstract][Full Text] [Related]
4. Conditional deletion of TGF-βR1 using Langerin-Cre mice results in Langerhans cell deficiency and reduced contact hypersensitivity.
Zahner SP; Kel JM; Martina CA; Brouwers-Haspels I; van Roon MA; Clausen BE
J Immunol; 2011 Nov; 187(10):5069-76. PubMed ID: 21998450
[TBL] [Abstract][Full Text] [Related]
5. Langerhans cells are required for UVR-induced immunosuppression.
Schwarz A; Noordegraaf M; Maeda A; Torii K; Clausen BE; Schwarz T
J Invest Dermatol; 2010 May; 130(5):1419-27. PubMed ID: 20090769
[TBL] [Abstract][Full Text] [Related]
6. Identification of a novel population of Langerin+ dendritic cells.
Bursch LS; Wang L; Igyarto B; Kissenpfennig A; Malissen B; Kaplan DH; Hogquist KA
J Exp Med; 2007 Dec; 204(13):3147-56. PubMed ID: 18086865
[TBL] [Abstract][Full Text] [Related]
7. The mandatory role of IL-10-producing and OX40 ligand-expressing mature Langerhans cells in local UVB-induced immunosuppression.
Yoshiki R; Kabashima K; Sakabe J; Sugita K; Bito T; Nakamura M; Malissen B; Tokura Y
J Immunol; 2010 May; 184(10):5670-7. PubMed ID: 20400709
[TBL] [Abstract][Full Text] [Related]
8. Visualization and characterization of migratory Langerhans cells in murine skin and lymph nodes by antibodies against Langerin/CD207.
Stoitzner P; Holzmann S; McLellan AD; Ivarsson L; Stössel H; Kapp M; Kämmerer U; Douillard P; Kämpgen E; Koch F; Saeland S; Romani N
J Invest Dermatol; 2003 Feb; 120(2):266-74. PubMed ID: 12542532
[TBL] [Abstract][Full Text] [Related]
9. Langerhans cells are required for efficient presentation of topically applied hapten to T cells.
Bennett CL; Noordegraaf M; Martina CA; Clausen BE
J Immunol; 2007 Nov; 179(10):6830-5. PubMed ID: 17982073
[TBL] [Abstract][Full Text] [Related]
10. Langerin+ dermal dendritic cells are critical for CD8+ T cell activation and IgH γ-1 class switching in response to gene gun vaccines.
Stoecklinger A; Eticha TD; Mesdaghi M; Kissenpfennig A; Malissen B; Thalhamer J; Hammerl P
J Immunol; 2011 Feb; 186(3):1377-83. PubMed ID: 21187444
[TBL] [Abstract][Full Text] [Related]
11. Langerin expressing cells promote skin immune responses under defined conditions.
Wang L; Bursch LS; Kissenpfennig A; Malissen B; Jameson SC; Hogquist KA
J Immunol; 2008 Apr; 180(7):4722-7. PubMed ID: 18354196
[TBL] [Abstract][Full Text] [Related]
12. Selective AhR knockout in langerin-expressing cells abates Langerhans cells and polarizes Th2/Tr1 in epicutaneous protein sensitization.
Hong CH; Lin SH; Clausen BE; Lee CH
Proc Natl Acad Sci U S A; 2020 Jun; 117(23):12980-12990. PubMed ID: 32461368
[TBL] [Abstract][Full Text] [Related]
13. Insights into Langerhans cell function from Langerhans cell ablation models.
Kaplan DH; Kissenpfennig A; Clausen BE
Eur J Immunol; 2008 Sep; 38(9):2369-76. PubMed ID: 18792030
[TBL] [Abstract][Full Text] [Related]
14. Langerin+ dermal DC, but not Langerhans cells, are required for effective CD8-mediated immune responses after skin scarification with vaccinia virus.
Seneschal J; Jiang X; Kupper TS
J Invest Dermatol; 2014 Mar; 134(3):686-694. PubMed ID: 24126845
[TBL] [Abstract][Full Text] [Related]
15. Compensatory role of Langerhans cells and langerin-positive dermal dendritic cells in the sensitization phase of murine contact hypersensitivity.
Honda T; Nakajima S; Egawa G; Ogasawara K; Malissen B; Miyachi Y; Kabashima K
J Allergy Clin Immunol; 2010 May; 125(5):1154-1156.e2. PubMed ID: 20226508
[No Abstract] [Full Text] [Related]
16. Langerhans cells and more: langerin-expressing dendritic cell subsets in the skin.
Romani N; Clausen BE; Stoitzner P
Immunol Rev; 2010 Mar; 234(1):120-41. PubMed ID: 20193016
[TBL] [Abstract][Full Text] [Related]
17. Murine epidermal Langerhans cells and langerin-expressing dermal dendritic cells are unrelated and exhibit distinct functions.
Nagao K; Ginhoux F; Leitner WW; Motegi S; Bennett CL; Clausen BE; Merad M; Udey MC
Proc Natl Acad Sci U S A; 2009 Mar; 106(9):3312-7. PubMed ID: 19218433
[TBL] [Abstract][Full Text] [Related]
18. The dermis contains langerin+ dendritic cells that develop and function independently of epidermal Langerhans cells.
Poulin LF; Henri S; de Bovis B; Devilard E; Kissenpfennig A; Malissen B
J Exp Med; 2007 Dec; 204(13):3119-31. PubMed ID: 18086861
[TBL] [Abstract][Full Text] [Related]
19. Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells.
Kissenpfennig A; Henri S; Dubois B; Laplace-Builhé C; Perrin P; Romani N; Tripp CH; Douillard P; Leserman L; Kaiserlian D; Saeland S; Davoust J; Malissen B
Immunity; 2005 May; 22(5):643-54. PubMed ID: 15894281
[TBL] [Abstract][Full Text] [Related]
20. Skin langerin+ dendritic cells transport intradermally injected anti-DEC-205 antibodies but are not essential for subsequent cytotoxic CD8+ T cell responses.
Flacher V; Tripp CH; Haid B; Kissenpfennig A; Malissen B; Stoitzner P; Idoyaga J; Romani N
J Immunol; 2012 Mar; 188(5):2146-55. PubMed ID: 22291181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]